Bridging the innovation gap for neglected tropical diseases in Mexico:

capacity building for the development of a new generation of antipoverty vaccines 

Autores: Bottazzi Maria Elena, Dumonteil Eric, Valenzuela Jesus G, Betancourt Cravioto Miguel, Tapia Conyer Roberto, Hotez Peter J

Resumen

The neglected tropical diseases (NTDs) represent a group of chronic parasitic and related infections that promote poverty because of their impact on child development, pregnancy, and worker productivity. The estimated 20 million Mexicans who live below the poverty line suffer disproportionately fron a high prevalence of neglected tropical diseases such as amebiasis, Chagas disease, dengue, leishmaniasis, soil-transmitted helminth infections, trachoma, and vivax malaria. However, because the NTDs occur predominantly among the poor, new industrial and financial models are required to establish innovative technologies to address these conditions in Mexico and elsewhere in Latin America. In response, the Slim Initiative for Antipoverty Vaccine Development was established to foster a public/private partnership between key academic, government, and industrial institutions in the U.S. and Mexico. Initial emphasis will be placed on developing new vaccines for Chagas disease and leishmaniasis, two of the highest burden NTDs in Mexico and Mesoamerica.

Palabras clave: Public partnerships private partnerships vaccines product development technology transfer vaccine manufacture.

2011-05-05   |   883 visitas   |   Evalua este artículo 0 valoraciones

Vol. 68 Núm.2. Marzo-Abril 2011 Pags. 138-146 Bol Med Hosp Infant Mex 2011; 68(2)